Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-115.42%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-115.42%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-0.20%
40%
—
—
Never
—
5 Years
Score—
Net Growth-0.20%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
GT Biopharma Inc fundamental performance
Across GT Biopharma Inc's full reported history, from 2017 to 2025, revenue declined from $ 27K to $ 0.00 and net income went from -$ 144M to -$ 28M. Revenue increased in 0% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.30 | — |
1 Year2025-08-12 | $ 1.75 | -82.73% |
5 Years2021-08-12 | $ 324.30 | -99.91% |
10 Years2016-08-12 | $ 0.20 | 51.05% |
20 Years2006-08-11 | $ 0.28 | 7.89% |
30 Years1996-08-12 | $ 2.00 | -84.89% |
All Time2017-09-22 | $ 6.20 | -95.13% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time2017-09-22 |
|---|---|---|---|---|---|---|---|
| Price | $ 0.30 | $ 1.75 | $ 324.30 | $ 0.20 | $ 0.28 | $ 2.00 | $ 6.20 |
| Return | — | -82.73% | -99.91% | 51.05% | 7.89% | -84.89% | -95.13% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 28M | $ 6M |
| 2024 | $ 0.00 | -$ 13M | $ 3M |
| 2023 | $ 0.00 | -$ 7M | $ 13M |
| 2022 | $ 0.00 | -$ 20M | $ 16M |
| 2021 | $ 0.00 | -$ 58M | $ 31M |
| 2020 | $ 0.00 | -$ 28M | $ 5M |
| 2019 | $ 0.00 | -$ 38M | $ 28K |
| 2018 | $ 0.00 | -$ 259M | $ 60K |
| IPO2017 | $ 27K | -$ 144M | $ 576K |
Explore beyond GTBP
You're looking at GT Biopharma Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
